BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 26206949)

  • 1. Sorafenib Action in Hepatitis B Virus X-Activated Oncogenic Androgen Pathway in Liver through SHP-1.
    Wang SH; Yeh SH; Shiau CW; Chen KF; Lin WH; Tsai TF; Teng YC; Chen DS; Chen PJ
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26206949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sorafenib overcomes the chemoresistance in HBx-expressing hepatocellular carcinoma cells through down-regulation of HBx protein stability and suppresses HBV gene expression.
    Kim HY; Jung HU; Yoo SH; Yoo KS; Cheong J; Park BS; Yun I; Yoo YH
    Cancer Lett; 2014 Dec; 355(1):61-9. PubMed ID: 25218348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation.
    Yu Z; Feng H; Zhuo Y; Li M; Zhu X; Huang L; Zhang X; Zhou Z; Zheng C; Jiang Y; Le F; Yu DY; Cheng AS; Sun X; Gao Y
    Cell Oncol (Dordr); 2020 Dec; 43(6):1129-1145. PubMed ID: 32623699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HBx-induced androgen receptor expression in HBV-associated hepatocarcinoma is independent of the methylation status of its promoter.
    Zhu R; Zhang JS; Zhu YZ; Fan J; Mao Y; Chen Q; Zhu HG
    Histol Histopathol; 2011 Jan; 26(1):23-35. PubMed ID: 21117024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3beta kinase pathways.
    Yang WJ; Chang CJ; Yeh SH; Lin WH; Wang SH; Tsai TF; Chen DS; Chen PJ
    Hepatology; 2009 May; 49(5):1515-24. PubMed ID: 19205031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription.
    Wu MH; Ma WL; Hsu CL; Chen YL; Ou JH; Ryan CK; Hung YC; Yeh S; Chang C
    Sci Transl Med; 2010 May; 2(32):32ra35. PubMed ID: 20484730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between androgen receptor expression and hepatitis B virus X protein and its clinical significance in hepatocellular carcinoma].
    Gu DH; Zhu YZ; Wang X; Bai ZC; Ping JL; Chen Q; Zhu R
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):282-7. PubMed ID: 23985257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle-related kinase mediates viral-host signalling to promote hepatitis B virus-associated hepatocarcinogenesis.
    Yu Z; Gao YQ; Feng H; Lee YY; Li MS; Tian Y; Go MY; Yu DY; Cheung YS; Lai PB; Yu J; Wong VW; Sung JJ; Chan HL; Cheng AS
    Gut; 2014 Nov; 63(11):1793-804. PubMed ID: 24440987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma.
    Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP
    Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level.
    Chiu CM; Yeh SH; Chen PJ; Kuo TJ; Chang CJ; Chen PJ; Yang WJ; Chen DS
    Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2571-8. PubMed ID: 17259306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
    Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
    World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.
    Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z
    Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
    Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
    Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin.
    Huang JF; Guo YJ; Zhao CX; Yuan SX; Wang Y; Tang GN; Zhou WP; Sun SH
    Hepatology; 2013 May; 57(5):1882-92. PubMed ID: 23239537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
    Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
    Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The expression of hepatitis B virus X protein and cyclooxygenase-2 in hepatitis B virus-related hepatocellular carcinoma: correlation with microangiogenesis and metastasis, and what is the possible mechanism].
    Liu KG; Shao XL; Xie HH; Xu L; Zhao H; Guo ZH; Li L; Liu J
    Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):831-6. PubMed ID: 21138631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of miR-193b sensitizes Hepatitis B virus-associated hepatocellular carcinoma to sorafenib.
    Mao K; Zhang J; He C; Xu K; Liu J; Sun J; Wu G; Tan C; Zeng Y; Wang J; Xiao Z
    Cancer Lett; 2014 Oct; 352(2):245-52. PubMed ID: 25034398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.